Statistics

Total Visits

Views
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 555

Total Visits per Month

February 2016 March 2016 April 2016 May 2016 June 2016 July 2016 August 2016
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 0 0 3 0 3 1 2

File Downloads

Views
4403[1].pdf 196

Top Country Views

Views
United States 281
Russia 89
Poland 53
Denmark 26
Canada 22
China 16
United Kingdom 11
Germany 10
France 6
Hong Kong 3

Top City Views

Views
Minneapolis 120
Spartanburg 67
Houston 31
Miami Beach 16
Toronto 14
Zhengzhou 6
Beijing 5
San Jose 5
Brighton 4
Ottawa 4